Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-11-03
1996-12-03
Reamer, James H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 31485
Patent
active
055808760
ABSTRACT:
This invention relates to a method for selectively enhancing the analgesic potency of a bimodally-acting opioid agonist such as morphine and simultaneously attenuating anti-analgesia, hyperalgesia, hyperexcitability, physical dependence and/or tolerance effects associated with the administration of the bimodally-acting opioid agonist. The method of the present invention comprises administering to a subject an analgesic or sub-analgesic amount of a bimodally-acting opioid agonist such as morphine and an amount of an excitatory opioid receptor antagonist such as naltrexone or nalmefene effective to enhance the analgesic potency of the bimodally-acting opioid agonist and attenuate the anti-analgesia, hyperalgesia, hyperexcitability, physical dependence and/or tolerance effects of the bimodally-acting opioid agonist.
REFERENCES:
patent: 3332950 (1967-07-01), Blumberg et al.
patent: 4760069 (1988-07-01), Rzeszotarski et al.
patent: 4882335 (1989-11-01), Sinclair
patent: 4889860 (1989-12-01), Rzeszotarski et al.
patent: 5075341 (1991-12-01), Mendelson et al.
patent: 5086058 (1992-02-01), Sinclair
patent: 5096715 (1992-03-01), Sinclair
patent: 5317022 (1994-05-01), Borsodi et al.
patent: 5321012 (1994-06-01), Mayer et al.
patent: 5352680 (1994-10-01), Portoghese et al.
Shen and Crain, Regulatory Peptides, in press (1993).
Shen and Crain, Brain Research, 597:74-83 (1992).
Shen and Crain, Brain Research, 575:13-24 (1992).
Wang, et al. Chinese J. Pharm. Toxicol, 6:36-40 (1992) and English translation thereof.
Bo-Yi, Qin, New Drugs and Clinical Remedies, 12:119-123 (1992), (English translation thereof).
Lange, et al., Toxicol. Applied Pharm., 54:177-186 (1980).
Terwillinger et al., Brain Research, 548:100-110 (1991).
Shen, et al., Brain Research, 559:130-138 (1991).
Crain and Shen, Trends Pharmacol. Sci., 11:77-81 (1990).
Fujimoto, et al., Neuropharmacol., 29: 609-617 (1990).
Shen and Crain, Brain Research, 531: 1-7 (1990).
Shen and Crain, Brain Research, 491: 227-242 (1989).
North, Trends Neurosci., 9: 114-117 (1986).
Magnan, et al., Naunyn-Schmiedeberg's Arch. Pharmacol., 319: 197-205 (1982).
Bentley and Hardy, J. American Chem. Soc., 89: 3281-3286 (1967).
Bentley and Hardy, Proc. Chem. Soc., p. 220 (1963).
Holmes, B. B. and J. M. Fujimoto, Anesth. Analg., 77:1166-1173 (1993).
Miaskowski, C. and J. D. Levine, Brain Research, 596: 41-45 (1992).
Vaccarino, A. L., et al., Pain, 36:103-109 (1989).
Cappell, H., et al., Pharmacology Biochemistry & Behavior, vol. 34 pp. 425-427 (1989).
Crain Stanley M.
Shen Ke-Fei
Albert Einstein College of Medicine of Yeshiva University (a Div
Reamer James H.
LandOfFree
Method of simultaneously enhancing analgesic potency and attenua does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of simultaneously enhancing analgesic potency and attenua, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of simultaneously enhancing analgesic potency and attenua will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-785844